New combo therapy aims to control blood cancer without a cure
NCT ID NCT06378138
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug combination (ICP-248 plus orelabrutinib) in people with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma. The goal is to see if the combination is safe and tolerable. About 226 adults aged 18 to 80 with measurable disease and a need for treatment will participate. This is not a cure; it aims to control the disease long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anhui Provincial Hospital (The First Affiliated Hospital of University of Science and Technology of China)
RECRUITINGHefei, Anhui, 230001, China
-
Bethune First Hospital of Jilin University
RECRUITINGChangchun, Jilin, 130061, China
-
Blood Diseases Hospital of Chinese Academy of Medical Sciences
RECRUITINGTianjin, Tianjin Municipality, 300020, China
-
Changzhou First People's Hospital
NOT_YET_RECRUITINGChangzhou, Jiangsu, 213003, China
-
Fujian Medical University Union Hospital
RECRUITINGFuzhou, Fujian, 350001, China
-
Gansu Provincial People's Hospital
RECRUITINGLanzhou, Gansu, 730000, China
-
Guangdong General Hospital
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510080, China
-
Henan Cancer Hospital
RECRUITINGZhenzhou, Henan, 450003, China
-
Henan Provincial People's Hospital
RECRUITINGZhengzhou, Henan, 463599, China
-
Huai'an First People's Hospital
RECRUITINGHuai'an, Jiangsu, 223300, China
-
Huashan Hospital
RECRUITINGShanghai, Shanghai Municipality, 200040, China
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, 410031, China
-
Jiangsu Province Hospital
RECRUITINGNanjing, Jiangsu, 210029, China
-
Jining First People's Hospital
RECRUITINGJining, Shandong, 272011, China
-
Linyi City Cancer Hospital
RECRUITINGLinyi, Shandong, 276002, China
-
Nanfang Hospital of Southern Medical University
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510515, China
-
Nanyang City Center Hospital
RECRUITINGNanyang, Henan, 473005, China
-
Peking University Third Hospital
RECRUITINGBeijing, Beijing Municipality, 100191, China
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, 250012, China
-
Shaanxi Provincial People's Hospital
RECRUITINGXi’an, Shanxi, 710068, China
-
Shandong Cancer Hospital
RECRUITINGJinan, Shandong, 250117, China
-
Shandong Provincial Hospital
RECRUITINGJinan, Shandong, 250021, China
-
Shanghai Huashan Hospital
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, 201108, China
-
Shanxi Cancer Hospital
NOT_YET_RECRUITINGTaiyuan, Shanxi, 030013, China
-
Shengjing Hospital affiliated to China Medical University
RECRUITINGShenyang, Liaoning, Liaoning, China
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510055, China
-
The Affiliated Cancer Hospital of Xinjiang Medical University
RECRUITINGÜrümqi, Xinjiang Uygur Autonomous Region, 830000, China
-
The Affiliated Hospital of North China University of Science and Technology
RECRUITINGTangshan, Hebei, 063000, China
-
The Affiliated Hospital of Zunyi Medical University
NOT_YET_RECRUITINGZunyi, Guizhou, 563003, China
-
The First Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, Anhui, 230022, China
-
The First Affiliated Hospital of Bengbu Medical College
RECRUITINGBengbu, Anhui, 233004, China
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, Chongqing Municipality, 400016, China
-
The First Affiliated Hospital of Guangxi Medical University
NOT_YET_RECRUITINGNanning, Guangxi, 530021, China
-
The First Affiliated Hospital of Henan University of Science and Technology
RECRUITINGLuoyang, Henan, 471003, China
-
The First Affiliated Hospital of Kunming Medical University
RECRUITINGKunming, Yunnan, 650032, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
-
The First Affiliated Hospital of Xiamen University
RECRUITINGXiamen, Fujian, 361003, China
-
The First Affiliated Hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310003, China
-
The Fourth Hospital of Hebei Medical University
RECRUITINGShijiazhuang, Hebei, 050010, China
-
The People's Hospital Affiliated to Ningbo University
RECRUITINGNingbo, Zhejiang, 315040, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
RECRUITINGXi’an, Shanxi, 710004, China
-
The Second Hospital of Dalian Medical University
RECRUITINGDalian, Liaoning, 116023, China
-
The Second Hospital of Shanxi Medical University
NOT_YET_RECRUITINGTaiyuan, Shanxi, 030001, China
-
The Second Xiangya Hospital, Central South University
RECRUITINGChangsha, Hunan, 410012, China
-
Tianjin Medical University Cancer Institute and Hospital
RECRUITINGTianjin, Tianjin Municipality, 300181, China
-
Tianjin People's Hospital
NOT_YET_RECRUITINGTianjin, Tianjin Municipality, 300120, China
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430011, China
-
Union Hospital Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430022, China
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
-
Xinqiao Hospital, the Second Affiliated Hospital of Army Military Medical University
RECRUITINGChongqing, Chongqing Municipality, 400037, China
-
Yibin Second People's Hospital
RECRUITINGYibin, Sichuan, 644002, China
-
Yichang Central People's Hospital
RECRUITINGYichang, Hubei, 443003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- AI platform aims to unlock Real-World cancer data on a massive scale
- Can a Three-Drug combo outsmart High-Risk CLL?
- Can a gentler dose of zanubrutinib keep CLL at bay in the very elderly?
- Can a Two-Drug combo wipe out hidden leukemia cells?